Riskpilot← Back to searchSign inGet full accessJefamed AB
ABActiveOrg 5593718488Torsgatan 49General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2024
SEK 178K
EBITDA margin
82.1%
+4378% vs 2023
Equity ratio
89.6%
Financial strength
Net profit 2024
SEK 117K
+4073% vs 2023
| Revenue | SEK 178K | — |
| EBITDA | SEK 146K | +4378% |
| Net profit | SEK 117K | +4073% |
| Total assets | SEK 285K | +107% |
| Equity | SEK 255K | +85% |
| Employees | 0 | — |
Legal name
Jefamed AB
Org number
5593718488
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva konsultverksamhet inom vård och utbildning.
Address
Torsgatan 49
Email
fabian.arnberg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 154 | 0 | 178 |
| Staff expenses | — | — | — |
| EBITDA | 146 | −3 | 146 |
| Depreciation & amort. | — | — | — |
| EBIT | 146 | −3 | 146 |
| Net financials | — | 0 | 0 |
| Profit before tax | 146 | −3 | 147 |
| Tax | −30 | — | −30 |
| Net profit | 116 | −3 | 117 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 208 | 138 | 285 |
| Equity | 141 | 138 | 255 |
| Long-term debt | — | — | — |
| Short-term debt | 67 | 0 | 30 |
| Total debt | 67 | — | 30 |
EBITDA margin
82.1%
This company
15.8%
Market median
+420% vs market
20222024
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20222024
Return on equity
46.0%
This company
18.4%
Market median
+150% vs market
20222024
Net profit margin
65.7%
This company
8.1%
Market median
+711% vs market
20222024
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20222024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jefamed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessika Birgitta Arnberg Sandor | Chief Executive Officer | 0 companies |
| Fabian Lennart Olof Arnberg Sandor | Chairman | 0 companies |
| Knut Filip Rikard Arnberg | Deputy Board Member | 0 companies |